International Business Machines Corporation research snapshot
IBM AI stock analysis currently reads International Business Machines as a high-quality software, hybrid cloud, and services company whose free cash flow remains strong, but whose stock has fallen sharply after a mixed Q2 2026 report. The stock closed at $223.65 on July 31, 2026, with a mechanically verified market capitalization near $210.71 billion, down roughly 26% from its June 2, 2026 high of $332.46. IBM reported Q2 revenue of $17.2 billion, up only 1%, with an IBM Z mainframe shortfall cutting Transaction Processing and Infrastructure results. The AI view stays constructive on Red Hat, Data, Distributed Infrastructure, free cash flow, and the dividend, but it is not a price prediction: upside depends on software reacceleration, AI bookings, and quantum optionality, while downside risk rises if the Z shortfall persists, consulting stays soft, securities investigations expand, or acquisition-related debt limits flexibility. This page is for informational research only and is not investment advice.
Current price
$223.65
Market cap
$210.71 billion
AI score
58 / 100
Rating
Quality software and free cash flow engine with an execution setback and credibility overhang
Trend status
Downtrend below 50-day and 200-day moving averages
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | IBM sells mission-critical software, hybrid cloud platforms, consulting, infrastructure, financing, and support to large enterprises and governments. The franchise economics are anchored in Software and the IBM Financing-supported installed base. | High |
| Moat | The moat comes from switching costs, mainframe and transaction-processing depth, Red Hat ecosystem reach, enterprise relationships, patents, and regulated-workload trust. It is strongest in mission-critical workloads, not generic consulting. | Medium-high |
| Management | Arvind Krishna has pushed IBM toward hybrid cloud, AI, automation, and quantum while pruning assets. The Q2 miss and the late-quarter deal slippage are a credibility test, and capital allocation is now strained by large acquisitions and a heavy quantum investment plan. | High |
| Financial trend | FY2025 revenue was $67.535 billion, net income was about $10.59 billion, and free cash flow was $14.7 billion. Q2 2026 revenue was $17.162 billion, up 1%, with first-half free cash flow of $4.8 billion. | High |
| Valuation | At $223.65, verified valuation math shows about 19.8x trailing EPS, 15.3x free cash flow per share, 3.05x sales, and a 3.02% dividend yield, all well below the levels seen in early July 2026. | Medium-high |
| Technical trend | IBM closed at $223.65 on July 31, 2026, below its 50-day moving average near $260 and its 200-day moving average near $270, after falling from a $332.46 high reached on June 2, 2026. | Medium |
| Risk level | Risks include the IBM Z shortfall and its software stack, slower consulting growth, AI disruption of legacy modernization, securities investigations announced after the Q2 report, heavy debt, and aggressive quantum spending. | Medium-high |
| AI confidence | Descriptive research confidence is high because IBM has rich filings and a fresh Q2 2026 release. Forward return confidence is lower because guidance was cut, investigations are open, and multiples can move quickly. | High data confidence |
| Investment certainty | The margin of safety is wider than in early July because the stock fell faster than fundamentals, but the Q2 execution failure means investors should require evidence of a software and Infrastructure recovery before treating the valuation as a floor. | Medium |
IBM AI stock forecast
The IBM AI stock forecast is scenario-based, not a precise price promise. Using the July 31, 2026 close of $223.65, trailing EPS near $11.27, and a three-year model, the tested outputs were about $179 in a bear case, $262 in a base case, and $330 in a bull case before dividends. These depend on EPS growth assumptions and target multiples and can be wrong.
$305 to $335
More likely if Red Hat, Data, and watsonx software reaccelerate, the IBM Z program recovers after the capex reprioritization, generative AI and quantum news convert into revenue, and IBM grows EPS near a high-single-digit rate with free cash flow rising toward the $15 billion-plus area.
$250 to $270
More likely if IBM grows EPS at a mid-single-digit rate in line with its 4% to 5% constant currency revenue guidance, consulting improves only gradually, Z stabilizes, and the market keeps a multiple near its current level.
$170 to $185
More likely if the Z shortfall extends into the software stack, consulting demand weakens further, the securities investigation expands, quantum spending pressures margins, or the market re-rates IBM toward a lower mature-technology multiple.
IBM AI technical analysis
IBM AI technical analysis is negative in the short term as of the August 2, 2026 data cutoff. IBM closed at $223.65 on July 31, 2026, down about 26% from its June 2 high of $332.46, and it trades below both its 50-day moving average near $260 and its 200-day moving average near $270. The RSI near 41 suggests the selloff is not deeply oversold, so the downtrend can extend. Because this static page does not fetch request-time chart data, levels should be confirmed in a live chart before use.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $223.65 | StockAnalysis reported the July 31, 2026 close at $223.65. |
| 52-week high | $332.46 | StockAnalysis reported this high was reached on June 2, 2026, before the Q2 report. |
| 52-week low | $199.19 | StockAnalysis reported this low within the current 52-week range. |
| Near support | $210 to $218 | This zone sits just under the July 31 close and near the post-earnings low area. Holding it would give the first sign of stabilization. |
| Deeper support | $199 to $205 | The 52-week low area near $199 is the last structural support before a lower price range opens. |
| Near resistance | $235 to $245 | This covers the average analyst target near $244 and the gap left by the post-earnings decline. |
| 50-day moving average | $260.44 | StockAnalysis reported this average. Reclaiming it would signal a shift from downtrend to consolidation. |
| 200-day moving average | $270.49 | StockAnalysis reported this average. It is now overhead resistance until a durable recovery forms. |
| Momentum | Negative short-term | The stock is below both moving averages with an RSI near 41, so momentum is weak but not yet at oversold extremes. |
| Volume | Elevated on the decline | Average 20-day volume rose to about 13.6 million shares as selling accelerated after the Q2 report. |
| Invalidation | Close below $199 | A decisive close below the 52-week low area would confirm the downtrend is extending rather than stabilizing. |
IBM AI trading strategy
The IBM AI trading strategy below is a rules-based research framework, not personal investment advice. It connects IBM business milestones with technical confirmation, predefined invalidation levels, and fresh source-backed monitoring data.
Do not chase a falling stock. Wait for IBM to reclaim the $235 to $245 area on rising volume and hold it, then confirm that software, Red Hat, and Data growth stays healthy and that the securities investigation does not expand.
The trend setup is invalid if IBM closes below $199, the 52-week low area, or if another quarter shows a wider Z and Transaction Processing decline.
If IBM holds $210 to $218 and stabilizes near the $199 to $205 zone without a business thesis break, compare the oversold bounce with free cash flow delivery, consulting signs, and debt after the acquisition program.
Do not average down without a predefined maximum loss and a fresh review of balance sheet, investigation, and AI disruption risk.
Track software revenue, Red Hat and Data growth, the Z program recovery, consulting signings, free cash flow, debt, dividend coverage, and management commentary on the securities investigation and quantum investment plan.
Reduce confidence when the stock moves mainly on investigation or quantum headlines without matching revenue, margin, or cash-flow evidence.
Investment research summary
IBM is paid because large organizations need reliable hybrid cloud, automation, transaction processing, mainframe, consulting, and AI tooling for systems that cannot easily fail or move quickly to public-cloud-only architectures.
IBM benefits from switching costs, long enterprise relationships, Red Hat ecosystem depth, mainframe installed base, software support contracts, patents, and credibility with regulated industries. The moat is strongest in mission-critical workloads rather than generic consulting.
The thesis fails if the Z shortfall spreads to the software stack, consulting stays weak, AI reduces demand for legacy modernization, quantum spending pressures returns, acquisitions raise debt without raising cash flow, or the securities investigation expands.
Arvind Krishna has shifted IBM toward hybrid cloud, AI, automation, and quantum while pruning lower-growth assets. The key test is whether the Z miss was a one-quarter capex event and whether the large acquisition and quantum investment program turns into durable software and free cash flow.
IBM sits inside long-term enterprise AI, hybrid cloud, cybersecurity, data governance, and quantum-computing trends. The trend is favorable, but competition from Microsoft, hyperscalers, Accenture, ServiceNow, Oracle, and AI-native tools keeps returns contested.
At roughly 19.8x trailing EPS and 15.3x free cash flow per share with a 3.02% dividend yield, IBM is priced far below its early-July valuation. The margin of safety depends on software reacceleration, Z recovery, high cash conversion, and disciplined debt and quantum spending.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| IBM price | $223.65 at July 31, 2026 close | StockAnalysis | August 2, 2026 |
| Market capitalization | $210.71 billion, verified as $223.65 x 942.13 million shares | financial_rigor.py market cap verification | August 2, 2026 |
| Shares outstanding | 942.13 million shares | StockAnalysis | August 2, 2026 |
| Q2 2026 revenue | $17.162 billion, up 1%; Software $7.761 billion, Consulting $5.327 billion, Infrastructure $3.835 billion, Financing $186 million | IBM Q2 2026 results | August 2, 2026 |
| Q2 2026 earnings per share | GAAP diluted EPS $2.27, down 2%; operating (non-GAAP) EPS $2.93, up 5% | IBM Q2 2026 results | August 2, 2026 |
| IBM Z shortfall | Infrastructure down 7% with IBM Z down 42%; Distributed Infrastructure up 37% with a near $500 million backlog | IBM Q2 2026 results | August 2, 2026 |
| FY2025 revenue | $67.535 billion, cross-validated with IBM, StockAnalysis, and Macrotrends | IBM 2025 annual report | August 2, 2026 |
| FY2025 free cash flow | $14.7 billion, up $2.0 billion year over year | IBM Q4 2025 results | August 2, 2026 |
| First-half 2026 cash flow | Net cash from operating activities of $7.8 billion and free cash flow of $4.8 billion for the six months ended June 30, 2026 | IBM Q2 2026 results | August 2, 2026 |
| Cash and debt | $8.2 billion cash, restricted cash and marketable securities; $62.0 billion total debt including $13.0 billion IBM Financing debt | IBM Q2 2026 results | August 2, 2026 |
| Full-year 2026 guidance | Constant currency revenue growth of 4% to 5% and free cash flow up about $1 billion year over year | IBM Q2 2026 results | August 2, 2026 |
| Valuation check | 19.84x trailing EPS, 15.28x free cash flow per share, 3.05x sales, 3.02% dividend yield | financial_rigor.py valuation verification | August 2, 2026 |
| Analyst consensus | Buy rating with an average price target near $244 across about 25 analysts | StockAnalysis | August 2, 2026 |
| Moving averages and range | 50-day moving average $260.44, 200-day moving average $270.49, 52-week range $199.19 to $332.46 | StockAnalysis | August 2, 2026 |
This IBM AI stock analysis page is an informational research tool. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast ranges are scenarios based on available public data as of the cutoff date and can be wrong.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
